According to a newly published market research report by 24LifeSciences, the global hospital-acquired infection diagnostics market was valued at USD 4.99 billion in 2024 and is projected to reach USD 7.75 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.6% during the forecast period 20252031. Hospital-acquired infections (HAIs) remain a critical concern in healthcare...